Abstract

The natural antibiotic teixobactin kills pathogenic bacteria without detectable resistance. The difficult synthesis and unfavourable solubility of teixobactin require modifications, yet insufficient knowledge on its binding mode impedes the hunt for superior analogues. Thus far, teixobactins are assumed to kill bacteria by binding to cognate cell wall precursors (Lipid II and III). Here we present the binding mode of teixobactins in cellular membranes using solid-state NMR, microscopy, and affinity assays. We solve the structure of the complex formed by an improved teixobactin-analogue and Lipid II and reveal how teixobactins recognize a broad spectrum of targets. Unexpectedly, we find that teixobactins only weakly bind to Lipid II in cellular membranes, implying the direct interaction with cell wall precursors is not the sole killing mechanism. Our data suggest an additional mechanism affords the excellent activity of teixobactins, which can block the cell wall biosynthesis by capturing precursors in massive clusters on membranes.

The natural antibiotic teixobactin kills bacteria by direct binding to their cognate cell wall precursors (Lipid II and III). Here authors use solid-state NMR to reveal the native binding mode of teixobactins and show that teixobactins only weakly bind to Lipid II in anionic cellular membranes.

Details

Title
Mode of action of teixobactins in cellular membranes
Author
Shukla Rhythm 1   VIAFID ORCID Logo  ; Medeiros-Silva, João 2   VIAFID ORCID Logo  ; Parmar Anish 3 ; Vermeulen Bram J A 2   VIAFID ORCID Logo  ; Das Sanjit 3 ; Paioni Alessandra Lucini 2 ; Shehrazade, Jekhmane 2 ; Lorent, Joseph 4   VIAFID ORCID Logo  ; Bonvin Alexandre M J J 2   VIAFID ORCID Logo  ; Baldus, Marc 2   VIAFID ORCID Logo  ; Moreno, Lelli 5 ; Veldhuizen Edwin J A 6 ; Breukink Eefjan 4   VIAFID ORCID Logo  ; Singh, Ishwar 3   VIAFID ORCID Logo  ; Weingarth Markus 2   VIAFID ORCID Logo 

 Utrecht University, NMR Spectroscopy, Bijvoet Centre for Biomolecular Research, Department of Chemistry, Faculty of Science, Utrecht, The Netherlands (GRID:grid.5477.1) (ISNI:0000000120346234); Utrecht University, Membrane Biochemistry and Biophysics, Bijvoet Centre for Biomolecular Research, Department of Chemistry, Utrecht, The Netherlands (GRID:grid.5477.1) (ISNI:0000000120346234) 
 Utrecht University, NMR Spectroscopy, Bijvoet Centre for Biomolecular Research, Department of Chemistry, Faculty of Science, Utrecht, The Netherlands (GRID:grid.5477.1) (ISNI:0000000120346234) 
 University of Lincoln, School of Pharmacy, JBL Building, Lincoln, UK (GRID:grid.36511.30) (ISNI:0000 0004 0420 4262); University of Liverpool, Antimicrobial Pharmacodynamics and Therapeutics, Department of Molecular and Clinical Pharmacology, Liverpool, UK (GRID:grid.10025.36) (ISNI:0000 0004 1936 8470); University of Liverpool, Department of Chemistry, The Robert Robinson Laboratories, Liverpool, UK (GRID:grid.10025.36) (ISNI:0000 0004 1936 8470) 
 Utrecht University, Membrane Biochemistry and Biophysics, Bijvoet Centre for Biomolecular Research, Department of Chemistry, Utrecht, The Netherlands (GRID:grid.5477.1) (ISNI:0000000120346234) 
 University of Florence, Department of Chemistry ‘Ugo Schiff’, Sesto Fiorentino (FI), Italy (GRID:grid.8404.8) (ISNI:0000 0004 1757 2304) 
 Utrecht University, Section Molecular Host Defence, Division Infectious Diseases & Immunology, Department Biomolecular Health Sciences, Faculty of Veterinary Medicine, CL Utrecht, The Netherlands (GRID:grid.5477.1) (ISNI:0000000120346234) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2409865660
Copyright
© The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.